Gene-RADAR® Platform
Infectious Disease Detection (e.g., COVID-19)
Development/ValidationActive
Key Facts
Indication
Infectious Disease Detection (e.g., COVID-19)
Phase
Development/Validation
Status
Active
Company
About Nanobiosym
Nanobiosym is a long-standing private biotechnology firm leveraging nanobiophysics to develop transformative diagnostic technologies. Its flagship platform, Gene-RADAR®, is designed to provide rapid, accurate, and portable molecular diagnostic testing, positioning the company in the decentralized and point-of-care testing market. Led by founder and CEO Dr. Anita Goel, the company has gained recognition through awards and partnerships, though it operates in a highly competitive and capital-intensive diagnostics landscape with a technology platform that has yet to achieve widespread commercial deployment.
View full company profile